Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind trial of Gel-One for hip osteoarthritis
jRCT2061240110Phase 3Recruiting
- Sponsor
- Seikagaku Corporation
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hip osteoarthritis comparing Gel-One with Placebo (2 arms). Primary endpoint: WOMAC pain subscore change from baseline. Started Feb 2025; status: recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on jRCT2061240110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061240110.